Key result
A safe minimum protamine dose to neutralize heparin after cardiopulmonary bypass is 75% of the calculated total dose, which is significantly lower than conventional dosing practices.
Why the study?
Protamine has potentially serious side effects and excessive protamine causes increased postoperative bleeding, requiring appropriate dosing at CPB completion to avoid residual heparin or excessive protamine.
Does a reduced minimum protamine dose safely neutralize heparin at the completion of cardiopulmonary bypass in patients undergoing cardiac surgery compared to conventional dosing?
Observational (n=216)
Does a reduced minimum protamine dose safely neutralize heparin at the completion of cardiopulmonary bypass in patients undergoing cardiac surgery compared to conventional dosing?
A significantly lower protamine dose than conventionally used can safely neutralize circulating heparin after cardiopulmonary bypass, which may decrease the risk of postoperative bleeding and protamine-related adverse events.
Answers are grounded in this paper and cite their sources.
May support lower protamine dosing to limit adverse events; leaves open randomized confirmation before practice change.
Systemic anticoagulation with heparin during cardiopulmonary bypass (CPB) should be neutralized by protamine administration to restore normal hemostasis. However, protamine has potentially serious side effects and excessive protamine can cause increased postoperative bleeding. Thus, our goal is to appropriately dose protamine at the completion of CPB to neutralize heparin so that neither residual heparin nor excessive protamine is present. We performed a retrospective study of 216 patients who underwent cardiac surgery to search for a safe minimum protamine dose (PD) when measuring heparin concentration (HC). In addition, we developed a formula to determine PD using total heparin dose (THD) and CPB time without measuring HC. When protamine-to-heparin ratio (P-to-H) is set at 1 mg protamine to 100 international unit (IU) heparin in HMS Plus Hemostasis Management System (HMS), we determined that 75% of the calculated total PD is a safe minimum PD to sufficiently neutralize circulating heparin after CPB. On average, this translates into either .37 mg protamine/100 IU heparin of THD or .54 mg/100 IU of the first heparin bolus. The formula we developed to calculate PD without measuring HC can provide a PD that strongly agrees with the safe minimum PD when measuring HC. The safe minimum PD to neutralize circulating heparin after CPB can be significantly lower than conventional dosing practices. Reduction of PD may decrease the risk of postoperative bleeding and protamine-related adverse events. Based on our data, we decreased P-to-H in HMS to examine whether it is possible to reduce PD further than the safe minimum PD determined in this study.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2021) conducted an observational in Cardiac surgery requiring cardiopulmonary bypass (n=216). Minimum protamine dose vs. Conventional dosing practices was evaluated on Safe minimum protamine dose to sufficiently neutralize circulating heparin. A safe minimum protamine dose to neutralize heparin after cardiopulmonary bypass is 75% of the calculated total dose, which is significantly lower than conventional dosing practices.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: